SCHEMBL3364338

SCHEMBL3364338

CCOC(=O)CN(OCCNC(=O)OCCOCCNC(=O)OCCOCCNC(=O)OCCOCCN)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ACHE P22303 8/20 0.36
L3MBTL1 Q9Y468 1/20 0.33
TLR2 O60603 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP1A2 P05177 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1064714 0.81 ACHE (0.42) ACHEL3MBTL1TLR2LMNASMN1; SMN2
SCHEMBL1065642 0.81 ACHE (0.42) ACHEL3MBTL1TLR2LMNASMN1; SMN2
SCHEMBL9980552 0.79 L3MBTL1 (0.43) ACHEL3MBTL1TLR2LMNASMN1; SMN2
SCHEMBL4761785 0.73 ACHE (0.44) ACHELMNASMN1; SMN2MEN1KMT2A
SCHEMBL12339214 0.73 ACHE (0.44) ACHELMNASMN1; SMN2MEN1KMT2A
SCHEMBL30786562 0.72 ACHE (0.57) ACHETLR2
SCHEMBL30786561 0.72 ACHE (0.57) ACHETLR2
SCHEMBL30733875 0.72 ACHE (0.57) ACHETLR2
SCHEMBL3364343 0.71 TLR2 (0.35) ACHEL3MBTL1TLR2CHRNB2CHRNB4
SCHEMBL22452414 0.70 ACHE (0.41) ACHEL3MBTL1TLR2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009093821-A9 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS CONJUGATED WITH AMINO ACIDS AND THEIR APPLICATION 주식회사 파나진 (KR) 2010-05-27 WO disclosed
WO-2009093821-A2 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS CONJUGATED WITH AMINO ACIDS AND THEIR APPLICATION PANAGENE INC. (KR) 2009-07-30 WO disclosed